A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
Condition: IgA Nephropathy and Focal Segmental Glomerulosclerosis Interventions: Drug: HS-10390 tablet; Drug: Placebo tablet Sponsor: Hansoh BioMedical R&D Company Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials